DPP-4
Les inhibiteurs de DPP-4 sont des composés qui inhibent la Dipeptidyl Peptidase-4, une enzyme impliquée dans l'inactivation des hormones incrétines, qui régulent le métabolisme du glucose. En inhibant la DPP-4, ces composés prolongent l'action des hormones incrétines, augmentant la sécrétion d'insuline et réduisant les niveaux de glucose dans le sang. Les inhibiteurs de DPP-4 sont largement utilisés dans le traitement du diabète de type 2 et dans les recherches axées sur les troubles métaboliques. Chez CymitQuimica, nous proposons des inhibiteurs de DPP-4 pour soutenir vos recherches en endocrinologie, gestion du diabète et maladies métaboliques.
94 produits trouvés pour "DPP-4".
Filtrer par
Pourcentage de pureté
0
100
|
0
|
50
|
90
|
95
|
100
- Tri par prix ascendant
- Tri par prix descendant
- Puretés inférieures
- Puretés supérieures
- Livraison estimée la plus rapide
Retagliptin Phosphate
CAS :Retagliptin Phosphate (SP 2086) is pharmaceutical composition of DPP-4 inhibitor, for treating type-2 diabetes.Formule :C19H21F6N4O7PDegré de pureté :98.70%Couleur et forme :SolidMasse moléculaire :562.3568Begelomab
CAS :Begelomab (SAND-26) is a mouse-derived monoclonal antibody targeting DPP-4/CD26. Begelomab can be used to study severe refractory inflammatory myopathies.Degré de pureté :97.8% (SDS-PAGE); 98.3% (SEC-HPLC) - 97.8% (SDS-PAGE); 98.3% (SEC-HPLC)Couleur et forme :Transparent LiquidMasse moléculaire :146.20 kDa (Predicted)DBPR108
CAS :DBPR108 is an orally bioavailable dipeptide-derived DPP4 inhibitor (IC50: 15 nM) and it has no inhibition on DDP8 and DPP9.Formule :C16H25FN4O2Degré de pureté :99.68%Couleur et forme :SolidMasse moléculaire :324.3937Denagliptin
CAS :Denagliptin is a small molecule dipeptidyl peptidase IV (DPP-4) inhibitor for the treatment of endocrine Ü metabolic diseases and can be used in the study ofFormule :C20H18F3N3ODegré de pureté :99.12%Couleur et forme :SolidMasse moléculaire :373.3716Saxagliptin hydrate
CAS :Saxagliptin hydrate (Onglyza hydrate) is a selective and reversible DPP4 inhibitor (IC50: 26 nM; Ki: 1.3 nM).Formule :C18H27N3O3Degré de pureté :99.52%Couleur et forme :SolidMasse moléculaire :333.4253Trelagliptin
CAS :Trelagliptin (SYR-472) is a highly specific and long-acting DPP-4 inhibitor.Formule :C18H20FN5O2Degré de pureté :98.88%Couleur et forme :SolidMasse moléculaire :357.3821Fotagliptin
CAS :Fotagliptin is a dipeptidyl peptidase IV inhibitor.Formule :C17H19FN6OCouleur et forme :SolidMasse moléculaire :342.37Linagliptin Methyldimer
CAS :Linagliptin Methyldimer is a potent dipeptidyl peptidase IV inhibitor, IC50=6 pM.Formule :C50H56N16O4Degré de pureté :99.91%Couleur et forme :SolidMasse moléculaire :945.0844AMG-222
CAS :AMG-222 (ALS-2-0426, ALS-20426) is a DPP-4 inhibitor and may be used in the treatment of type 2 diabetes.Formule :C32H39N9O3Couleur et forme :SolidMasse moléculaire :597.71(-)-Sitagliptin Carbamoyl Glucuronide
CAS :Minor phase II metabolite of DPP-4 inhibitor sitagliptin, found in rat and dog plasma.Formule :C23H23F6N5O9Couleur et forme :SolidMasse moléculaire :627.453DPP-4/GPR119 modulator 1
CAS :Orally active DPP-4 inhibitor/GPR119 agonist, Compound 22 lowers glucose, moderate hERG inhibition, IC50 4.9 µM, for diabetes research.Formule :C30H39ClN10O3Couleur et forme :SolidMasse moléculaire :623.15Sitagliptin fenilalanil hydrochloride
CAS :Sitagliptin fenilalanil hydrochloride is an orally active DPP-4 inhibitor. Sitagliptin fenilalanil hydrochloride is used in diabetes research.Formule :C25H25ClF6N6O2Degré de pureté :98.32%Couleur et forme :White SolidMasse moléculaire :590.955-Hydroxy saxagliptin hydrochloride
5-Hydroxy saxagliptin hydrochloride is the active metabolite of Saxagliptin and serves as a potent and selective DPP-4 inhibitor. The Ki values for 5-Hydroxy saxagliptin hydrochloride are 2.6 nM in humans and 2.9 nM in cynomolgus monkeys. This compound is applicable in the research of type 2 diabetes.Talabostat isomer mesylate
Talabostat isomer mesylate, a PT100/Val-boroPro variant, is a potent oral DPP-IV inhibitor (Ki: 0.18 nM).Formule :C10H23BN2O6SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :310.18SGLT2-IN-6
SGLT2-IN-6 (Compound 101) is an orally active SGLT2 inhibitor with IC₅₀ values of 0.8 nM, 6.7 nM, and 72 nM for SGLT2, SGLT1, and DPP4, respectively. In diabetic rat models, SGLT2-IN-6 controls blood glucose levels and increases active GLP-1 levels. It is suitable for research on type 2 diabetes.HAEGT
CAS :HAEGT is the first N-terminal 1-5 residues of GLP-1 peptide.Formule :C20H31N7O9Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :513.5016SGLT2-IN-5
SGLT2-IN-5 (Compound 99) is an orally active SGLT2 inhibitor with IC₅₀ values of 0.8 nM for SGLT2, 23 nM for SGLT1, and 58 nM for DPP4. In diabetic rat models, SGLT2-IN-5 effectively regulates blood glucose and increases the levels of active GLP-1. It is suitable for research on type 2 diabetes.Dutogliptin tartrate
CAS :Dutogliptin tartrate is an effective and selective oral dipeptide-peptide-4 (DPP4) inhibitor for the treatment of type 2 diabetes mellitus.Formule :C14H26BN3O9Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :391.18Ellipyrone A
Ellipyrone A: γ-pyrone macrocycle, inhibits DPP-4 (IC50=0.35mM), α-glucosidase (IC50=0.74mM), α-amylase (IC50=0.59mM).Formule :C25H34O8Couleur et forme :SolidMasse moléculaire :462.53Camegliptin
CAS :Cameglipti, a dipeptidyl peptidase IV (DPP-4) inhibitor, is used potentially for the treatment of type 2 diabetes.Formule :C20H28FN3O3Couleur et forme :SolidMasse moléculaire :377.45
